Sinemet® 100/25

DRUG2 trials

Sponsors

Bial - Portela C S.A.

Conditions

Parkinson DiseaseParkinson's Disease (PD)

Phase 1

Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa

CompletedNCT02169479

Bial - Portela C S.A.Parkinson's Disease (PD)

Start: 2008-09-30End: 2008-12-31Updated: 2015-08-17

Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics

CompletedNCT03091868

Bial - Portela C S.A.Parkinson Disease

Start: 2004-11-03End: 2005-02-28Updated: 2017-03-27